Why the study?
Does diabetes increase glycosylation and cross-linkage of cardiac myosin in post-mortem left ventricular muscle?
Does diabetes increase glycosylation and cross-linkage of cardiac myosin in post-mortem left ventricular muscle?
Diabetic patients exhibit increased glycosylation of left ventricular myosin, potentially contributing to the higher risk of congestive heart failure in this population.
Answers are grounded in this paper and cite their sources.
May link myosin glycosylation to diabetic cardiomyopathy risk; hypothesis-generating and requires prospective validation before clinical relevance.
We have investigated the possibility that post-translational modification of myosin by protein glycosylation and cross-linking occurs in cardiac myosin. Left ventricular muscle was obtained at post-mortem from 6 diabetic and 7 non-diabetic subjects. Myosin was extracted from muscle and purified using Sephadex chromatography followed by protein concentration. Glycosylation was estimated using boronate affinity chromatography with the myosin dissolved in a pyrophosphate buffer, the glycosylated myosin being displaced with sorbitol. Cross-linkage was assessed by fluorescence at 440 nm upon excitation at 370 nm. Diabetic subjects had significantly higher levels (p less than 0.02) of glycosylated myosin (median 6.0% (range 3.8-6.6%] than non-diabetic subjects (median 2.4% (range 0.3-4.2%] but there was no difference in the degree of cross-linkage as assessed by fluorescence (diabetic median 9.8 (range 6.5-17.0) arbitrary units; non-diabetic median 9.7 (range 6.0-11.4) arbitrary units). Glycosylation of left ventricular myosin may be of relevance to the excess risk of congestive cardiac failure in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Yudkin et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: